Clinical Trials Logo

Hypercholesteremia clinical trials

View clinical trials related to Hypercholesteremia.

Filter by:

NCT ID: NCT00408382 Completed - Clinical trials for Coronary Artery Disease

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

Start date: n/a
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease

NCT ID: NCT00376584 Completed - Hyperlipidemia Clinical Trials

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

Start date: July 2006
Phase: Phase 3
Study type: Interventional

This is a 12-week clinical trial in lipid clinic patients for whom niacin therapy is appropriate to evaluate the efficacy of MK0524 to improve the tolerability of extended-release niacin. There will be 6 scheduled clinic visits and 3 treatment arms.

NCT ID: NCT00347217 Completed - Hypercholesteremia Clinical Trials

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Start date: February 2006
Phase: Phase 4
Study type: Observational

Observational study to investigate the use and efficacy of CRESTOR 5 mg in reaching LDL-C target goals in both statin naïve and statin treated primary and secondary prevention patients at high risk for a cardiovascular event.

NCT ID: NCT00329160 Completed - Hypercholesteremia Clinical Trials

Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

Start date: October 2005
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to evaluate that 76 weeks of treatment with rosuvastatin calcium 2.5-20 mg results in no progression of coronary artery atherosclerotic volume as measured by intravascular ultrasonography (IVUS) imaging in hypercholesterolaemic subjects with coronary heart disease (CHD).

NCT ID: NCT00239330 Completed - Hypercholesteremia Clinical Trials

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to compare the efficacy of rosuvastatin 10 mg with atorvastatin 10 mg by assessment of the percentage of subjects who reach EAS LDL-C target goals after 12 weeks of therapy.

NCT ID: NCT00225589 Completed - Hypercholesteremia Clinical Trials

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Start date: August 2002
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to see if rosuvastatin will be effective in decreasing the thickness of the walls of the arteries in the neck for people who already have some evidence of thickening of these walls.

NCT ID: NCT00153738 Completed - Hypercholesteremia Clinical Trials

Phytosterol Supplementation and Cardiovascular Risk

Start date: March 2004
Phase: N/A
Study type: Interventional

This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementation.